Insider buying last 90 days
No open-market insider purchases were filed for CTVA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CTVA insider filing, plotted on the chart in Gekko.Open CTVA in Gekko
NYSE: CTVA
Corteva (CTVA) Stock Analysis & Forecast
$80.53−1.00 (−1.2%)
Close on Sep 18, 2026. Page updated Sep 19, 9:15 pm ET.
Gekko Brief
AI summaryCorteva closes at $80.53, down 1.2%, sitting between its 50-day average of $83.07 and 200-day average of $78.16. The GekkoIndex reads 64, placing the stock in the Accumulation zone, and price stands 3.1% above Gekko Fair Value of $78.13.
The week's news centers on regulatory and legal matters alongside analyst commentary. Corteva, Chemours and DuPont reached a $455 million PFAS settlement with North Carolina and 11 local entities, later described as a $590 million settlement addressing Fayetteville Works contamination, the largest environmental damages recovery in the state's history. Separately, California and 20 other attorneys general along with nine cities filed a motion seeking to block Corteva's planned spinoff of its seed business into a new company, Vylor, alleging the move shields PFAS liability. On the analyst side, Argus reiterated a "Buy" rating with a $91 price target, while KeyBanc reiterated a Sector Weight rating after Corteva's investor day, raising Seed EBITDA forecasts for 2027-2029 but trimming Crop Protection EBITDA estimates on muted pricing.
Over the next 44 days, earnings are due 3 November 2026, falling outside a typical 20-trading-day hold. No insider, Congress or unusual options activity appears in the current window. Seasonality from this point has averaged -2% over 20 trading days across 5 years, rising in 2 of them. Consensus among 15 firms includes 11 buy and 4 hold ratings, with a consensus target of $92.60.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $80.53200-day averageGekko Fair Value $78.13
Key stats
- Market cap
- $53.86B
- P/E ratio
- 49.1
- Forward P/E
- 19.3
- EPS, TTM
- $1.66
- Revenue, TTM
- $17.81B
- Profit margin
- 5.7%
- Dividend yield
- 0.89%
- Beta
- 0.58
- Volume
- 7.32M avg 5.14M
- 1-year return
- +14.0%
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±4.8%
- 50-day average
- $83.07
- 200-day average
- $78.16
- Next earnings
- Nov 3
- Shares outstanding
- 667.2M
Corteva swing-trade checklist
Corteva scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $80.53 sits between the 50-day ($83.07) and 200-day ($78.16) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
64, Accumulation
Reading 64 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
3.1% above
Price is within 5% of Gekko Fair Value (3.1% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 44 days
Next report Nov 3, 2026, 44 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−2.0% on average
From this point in the calendar, the next 20 trading days averaged −2% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Corteva stock chart and price history
Corteva closed at $80.53 on Sep 18, 2026, +14.0% over the past year, inside a 52-week range of $60.54 to $90.97.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +2.5%
- 3 months
- +2.5%
- 6 months
- +3.2%
- 1 year
- +14.0%
The full CTVA chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CTVA in Gekko
Follow Corteva through every session
Put CTVA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CTVA in GekkoFree for 7 days. No credit card required.
About Corteva
Corteva works in agriculture, supplying farmers with tools meant to raise yields and manage crop health. Its offerings include seed genetics and trait technologies designed to help crops withstand weather, disease, insects and herbicide use, along with improved nutritional qualities, plus digital tools that support decisions on product selection and profitability.
The business is divided into two segments. The Seed segment focuses on germplasm, traits and related digital farming support, while the Crop Protection segment supplies herbicides, insecticides, nitrogen stabilizers, pasture and range management products, and technologies applied to seeds and soil to guard against weeds, pests and disease. Its customers sit within the agricultural input trade, and it operates across the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East and Africa.
Corteva traces its founding to 1802 and is headquartered in Indianapolis, Indiana. Its shares are listed on the NYSE under the ticker CTVA.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Website
- corteva.com
Corteva GekkoIndex: the smart money zone
Corteva’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64, in the Accumulation zone, up 8.5 points over five sessions.
64Accumulation
Up 8.5 points over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 14 | +2.1% | +9.6% | ||
| Accumulation (current zone) | 182 | +0.9% | +3.4% | ||
| Neutral | 394 | +0.4% | +0.9% | ||
| Distribution | 69 | +0.2% | +2.1% | ||
| Selling | 3 | Too few readings yet | |||
Average CTVA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the CTVA price, zone by zone.Track CTVA in Gekko
Is Corteva stock overvalued? Gekko Fair Value
Corteva trades 3.1% above Gekko Fair Value of $78.13, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Corteva shares are worth, recalculated every trading day.
$78.13
Gekko Fair Value, Sep 19, 2026
3.1% above fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open CTVA in Gekko
Corteva insider and Congress trading
No open-market insider purchases were filed for Corteva, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CTVA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CTVA, plotted on the chart in Gekko.Open CTVA in Gekko
Buybacks
Corteva has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $250.0M
- As a share of market cap
- 0.46%
- Trailing four quarters
- $1.05B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds CTVA.
1added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Corteva earnings: next date and track record
Corteva reports on Nov 3, 2026 (44 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Nov 3, 2026
44 days away
- EPS estimate
- −$0.41
- Revenue estimate
- $2.65B
5 of 8reports beat the EPS estimate
±4.7%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Corteva reported strong Q2/H1 2026 results with net sales up 4%, operating EBITDA up 10%, and operating EPS up 14% year-over-year. Seed segment saw organic growth across all regions driven by premium genetics and trait adoption, plus growing licensing revenue. Crop protection delivered volume gains on new differentiated products with flat pricing. Company is on track for October 1 separation into two independent entities.
- Guidance
- Corteva raised its full year 2026 outlook following strong first-half execution. Management expressed continued confidence in guidance while monitoring crop protection pricing pressure and external macro factors including currency, trade flows, and geopolitical uncertainty.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $2.30 est $2.24 | $6.38B est $6.60B | −13.0% |
| May 5, 2026 | $1.50 est $1.17 | $4.91B est $4.64B | +0.1% |
| Feb 3, 2026 | $0.22 est $0.22 | $3.91B est $4.24B | +2.6% |
| Nov 4, 2025 | −$0.23 est −$0.45 | $2.62B est $2.47B | +2.6% |
| Aug 6, 2025 | $2.20 est $1.89 | $6.46B est $6.27B | −1.7% |
| May 7, 2025 | $1.13 est $0.87 | $4.42B est $4.54B | +7.1% |
| Feb 5, 2025 | −$0.06 est $0.20 | $3.98B est $4.04B | −5.1% |
| Nov 6, 2024 | −$0.76 est −$0.45 | $2.33B est $2.70B | −5.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Corteva stock forecast and analyst price targets
Analysts’ average 12-month price target for Corteva is $92.60, +15.0% from the last close, from 15 firms rating the stock in the last 90 days.
$92.60consensus 12-month target, +15.0% from the last close
Now $80.53Avg $92.60
Low $83High $103
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Argus Research | $91 | +13.0% |
| Sep 17 | KeyBanc | — | — |
| Sep 17 | Citi | $91 | +13.0% |
| Sep 16 | Barclays | $91 | +13.0% |
| Sep 16 | BMO Capital | $95 | +18.0% |
+3.4%average 20-day move after past Accumulation readings
−2.0%average move over the next 20 trading days in the last 5 years
±3.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Corteva seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, Corteva averaged −2.0% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.8% | 1 of 5 |
| Next 10 trading days | −2.7% | 2 of 5 |
| Next 15 trading days | −3.3% | 1 of 5 |
| Next 20 trading days | −2.0% | 2 of 5 |
| Next 30 trading days | −0.9% | 3 of 5 |
For scale, CTVA’s typical 20-trading-day move in either direction is about 4.8%.
Corteva market cap and key statistics
Corteva’s market cap is $53.86B, with a P/E ratio of 49.1 and revenue of $17.81B over the last twelve months.
Valuation
- Market cap
- $53.86B
- P/E ratio
- 49.1
- Forward P/E
- 19.3
- EPS, TTM
- $1.66
- Gekko Fair Value
- $78.13
Trading
- Volume
- 7.32M
- Avg volume, 20 days
- 5.14M
- 52-week high
- $90.97
- 52-week low
- $60.54
- Shares outstanding
- 667.2M
Financials
- Revenue, TTM
- $17.81B
- Profit margin
- 5.7%
- Return on equity
- 4.3%
- Quarterly earnings growth, YoY
- −9.9%
Risk and income
- Beta
- 0.58
- Typical daily move
- ±3.2%
- Typical 20-day move
- ±4.8%
- Dividend yield
- 0.89%
Corteva stock news this week
Coverage of Corteva this week reads neutral: 6 positive, 7 neutral and 5 negative headlines.
- Corteva (NYSE:CTVA) Receives "Buy" Rating from ArgusMarketBeat, Sep 18
- Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and DoleZacks Investment Research, Sep 18
- KeyBanc reiterates Corteva stock rating after investor day By Investing.comInvesting.com, Sep 17
- US' Chemours, DuPont, Corteva agree $455 mn PFAS settlementFibre2Fashion, Sep 16
- DOLE vs. CTVA: Which Stock Is the Better Value Option?Zacks Investment Research, Sep 16
- Corient Private Wealth LP Sells 19,693 Shares of Corteva, Inc. $CTVAMarketBeat, Sep 16
Corteva peers
Corteva’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| ADMArcher-Daniels-Midland | Neutral | 10.0% above |
| BGBunge | Accumulation | 2.2% below |
| PPCPilgrim's Pride | Accumulation | 38.0% below |
| AGROAdecoagro | Neutral | 17.3% above |
| SEBSeaboard | Neutral | 7.7% above |
| CALMCal-Maine Foods | Buying | 29.8% below |
A peer links to its own page where one exists.
Corteva stock FAQ
What is Corteva’s market cap?
Corteva’s market cap is $53.86B at the Sep 18, 2026 close of $80.53, with 667.2M shares outstanding. The shares trade on a P/E ratio of 49.1.
What is the Corteva stock forecast?
The consensus analyst 12-month price target for Corteva is $92.60, +15.0% from the last close. Of the 15 firms that rated the stock in the last 90 days, 11 rate it a buy, 4 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Corteva stock overvalued or undervalued?
On Gekko’s estimate Corteva is about fair value: the Sep 18, 2026 close of $80.53 is 3.1% above Gekko Fair Value of $78.13. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Corteva report earnings next?
Corteva is expected to report on Nov 3, 2026 (44 days away). Analysts expect earnings of −$0.41 per share on revenue of $2.65B. Corteva beat the earnings estimate in 5 of its last 8 reports, moving 4.7% on average across the report.
What is Corteva’s 52-week high and low?
Corteva’s 52-week high is $90.97 and its 52-week low is $60.54; it closed at $80.53 on Sep 18, 2026, +14.0% over the past year.
Is Corteva stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Corteva the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.